Corvus Pharmaceuticals, Inc. releases salary data. CEO sees compensation fall -19%

Corvus Pharmaceuticals, Inc. just filed its annual proxy statement, which details the salary information of its key executives. In 2019, the company's CEO made 1,098,039.

The table is included below:


























































































































































































































































































































































































Non‑equity





















































































Incentive













































Base




















Stock










Option










plan










All other

























Fiscal










salary




















awards










awards










compensation










compensation










Total





Name and principal position










year










($)










Bonus($)(3)










($)










($)(1)










($)










($) (2)










($)





Richard A. Miller, M.D.










2019










300,000
































795,039





















3,000










1,098,039





President and Chief Executive Officer










2018










300,000
































1,056,352





















3,000










1,359,352





Leiv Lea










2019










349,308
































397,520





















3,000










749,828





Chief Financial Officer










2018










319,342
































422,540





















3,000










744,882





Mehrdad Mobasaher, M.D.










2019










406,731










245,000





















702,425





















3,000










1,357,156





Vice President and Chief Medical Officer


















































































The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020

Auto Refresh

Feedback